First Tracks Biotherapeutics, Inc. (NasdaqGS: TRAX)
Health Care · Biotechnology · US
$48.70
-3.62% today · +156.3% 1Y
First Tracks Biotherapeutics, Inc. (NasdaqGS: TRAX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.05B and employs 104 people.
Over the last twelve months the share price has gained 156.3%, trading between 14.72 and 52.33.
Tweenvest scores First Tracks Biotherapeutics, Inc. across four factors: quality 48/100, value 100/100. Its strongest factor is value.
TRAX price history
Key figures
- Market cap
- $2.05B
- Revenue (TTM)
- —
- P/E
- -12.76
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $52.33
- 52-week low
- $14.72
- Avg volume (3M)
- —
- Shares outstanding
- 42.02M
- Employees
- 104
- Next earnings
- —
About First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
- ISIN
- US3371851029
- Founded
- 2019
- Listed since
- Apr 20, 2026
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Beam Therapeutics Inc.NasdaqGS: BEAM | $2.09B | $20.94 | -0.33% |
| Bonesupport Holding AB (publ)OM: BONEX | $2.07B | Skr323.80 | +1.63% |
| PharmaResearch Co., Ltd.KOSDAQ: A214450 | $2.06B | ₩265,000.00 | +2.71% |
| Biohaven Ltd.NYSE: BHVN | $2.06B | $13.65 | +5.81% |
| Sinocelltech Group LimitedSHSE: 688520 | $2.03B | CN¥28.84 | -2.80% |
| Vera Therapeutics, Inc.NasdaqGM: VERA | $2.03B | $28.10 | -3.24% |
| Veracyte, Inc.NasdaqGM: VCYT | $2.02B | $25.04 | -2.07% |
| Aurinia Pharmaceuticals Inc.NasdaqGM: AUPH | $2.00B | $14.89 | -1.59% |